Analysis of Lymph Node Metastasis and Tumor Deposit in the Short Gastric Mesentery Following Total Gastrectomy for Gastric Cancer

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-85
SponsorJichao Qin

About this trial

This study aims to explore lymph node metastasis in the short gastric mesentery following total gastrectomy with D2 lymphadenectomy plus complete mesogastric excision, providing evidence-based medicine for standardizing lymph node dissection in gastric cancer.

Eligibility criteria

Qualifiers

Aged older than 18 years and younger than 85 years

Primary gastric adenocarcinoma confirmed by preoperative pathology result

cT2-4aN0-3M0 at preoperative evaluation according to the American Joint 8 Committee on Cancer (AJCC) Cancer Staging Manual 8th Edition

Patients who received total gastrectomy with D2 lymphadenectomy plus complete mesogastric excision

Disqualifiers

Negative preoperative biopsy

Too late tumour stage or metastasis (cT4b/M1)

BMI>30 kg/m2

previous neoadjuvant chemotherapy or radiotherapy

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

150 Participants
are grouped into 1 trial group

Sponsors and collaborators

Jichao Qin

Lead sponsor

First Affiliated Hospital of Zhejiang University

Sponsor institution